CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:390 |
|---|---|
| Enthalten in: |
The New England journal of medicine - 390(2024), 14 vom: 11. Apr., Seite 1339-1341 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Marin-Esteban, Viviana [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antineoplastic Agents |
|---|
| Anmerkungen: |
Date Completed 12.04.2024 Date Revised 20.04.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1056/NEJMc2213180 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370881222 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370881222 | ||
| 003 | DE-627 | ||
| 005 | 20240421232100.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240411s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/NEJMc2213180 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1382.xml |
| 035 | |a (DE-627)NLM370881222 | ||
| 035 | |a (NLM)38598804 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Marin-Esteban, Viviana |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.04.2024 | ||
| 500 | |a Date Revised 20.04.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a CXCR4 protein, human |2 NLM | |
| 650 | 7 | |a plerixafor |2 NLM | |
| 650 | 7 | |a S915P5499N |2 NLM | |
| 650 | 7 | |a Receptors, CXCR4 |2 NLM | |
| 700 | 1 | |a Molet, Lucie |e verfasserin |4 aut | |
| 700 | 1 | |a Laganà, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Ciocan, Dragos |e verfasserin |4 aut | |
| 700 | 1 | |a Dominguez-Lafage, Clément |e verfasserin |4 aut | |
| 700 | 1 | |a Alouche, Nagham |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Gallego, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Mercier-Nomé, Françoise |e verfasserin |4 aut | |
| 700 | 1 | |a Jaracz-Ros, Agnieszka |e verfasserin |4 aut | |
| 700 | 1 | |a Beaupain, Blandine |e verfasserin |4 aut | |
| 700 | 1 | |a Bouligand, Jérôme |e verfasserin |4 aut | |
| 700 | 1 | |a Proust, Alexis |e verfasserin |4 aut | |
| 700 | 1 | |a Habib, Christophe |e verfasserin |4 aut | |
| 700 | 1 | |a Bonnin, Rémy A |e verfasserin |4 aut | |
| 700 | 1 | |a Girlich, Delphine |e verfasserin |4 aut | |
| 700 | 1 | |a Fouyssac, Fanny |e verfasserin |4 aut | |
| 700 | 1 | |a Schmutz, Jean-Luc |e verfasserin |4 aut | |
| 700 | 1 | |a Bursztejn, Anne-Claire |e verfasserin |4 aut | |
| 700 | 1 | |a Bellanné-Chantelot, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Bourrat, Emmanuelle |e verfasserin |4 aut | |
| 700 | 1 | |a Herfs, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Espéli, Marion |e verfasserin |4 aut | |
| 700 | 1 | |a Balabanian, Karl |e verfasserin |4 aut | |
| 700 | 1 | |a Schlecht-Louf, Géraldine |e verfasserin |4 aut | |
| 700 | 1 | |a Donadieu, Jean |e verfasserin |4 aut | |
| 700 | 1 | |a Bachelerie, Françoise |e verfasserin |4 aut | |
| 700 | 1 | |a Deback, Claire |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d 1945 |g 390(2024), 14 vom: 11. Apr., Seite 1339-1341 |w (DE-627)NLM000008184 |x 1533-4406 |7 nnns |
| 773 | 1 | 8 | |g volume:390 |g year:2024 |g number:14 |g day:11 |g month:04 |g pages:1339-1341 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1056/NEJMc2213180 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 390 |j 2024 |e 14 |b 11 |c 04 |h 1339-1341 | ||